I-Lamivudine iyisisigciwane esilaphazelekayo esetyenziselwa ukunyanga i- hepatitis B engapheliyo. Ithengiswa phantsi kwegama lohlobo lwe-Epivir-HBV kwakunye negama le-brand Epivir ekuphatheni intsholongwane kaGawulayo , ngokuqhelekileyo inxulumene namanye amayeza antiviral.
Enyanisweni, iLamivudine yayisungulwa ngokusesikweni njengonyango lweNtsholongwane kaGawulayo kwaye yafunyaniswa ukuba iyisirhubhululo esisebenzayo yokunyanga kwe-hepatitis B.
Injongo yokunyanga i-hepatitis B engapheliyo kufuneka iqulethe ukuphindaphinda kwintsholongwane kwaye oko kukuthintela umonakalo wesibindi. Okwangoku akukho nhlobo yeli gciwane e-United States. Uninzi oogqirha baseUnited States abaqhelekanga ukusebenzisa i-lamivudine njengonyango lokuqala lokuzikhethela izigulane ezine-hepatitis B (HPV), njengoko kukho ezinye iziyobisi ezisebenzayo . Nangona kunjalo, kusenokuba lukhethi oluhle kubantu abakhethiweyo.
Enye yeenzuzo ze-lamivudine xa kuthelekiswa nezinye iindlela zokonyango kukuba ayibizi kakhulu: Unyaka owodwa unyango kunye ne-lamivudine ye-hepatitis B unokubiza i-$ 4200. Nangona kunjalo, iindleko zeziyobisi ziyahluka ngokuxhomekeke kwizinto ezininzi, njengokuba unomshuwalense wezempilo, apho uhlala khona kwaye yiyiphi ikhemisi oyisebenzisayo.
Indlela iLamivudine ithathwa ngayo
I-Lamivudine ifumaneka kwifom yefayili kunye nepilisi. Esi sidakamizwa sithathwa imihla ngemihla ngomnyaka owodwa, kwaye singathathwa kunye okanye ngaphandle kokutya.
Umlinganiselo oqhelekileyo unokuthi ulungiswe kulabo abaneengxaki zeengtso.
Imiphumela
Isimo esingaqhathananga nesifo esingaba sisifo esibizwa ngokuthi i-lactic acidosis singakhula kwizigulane ezithatha i-lamivudine. Izigulane ezithatha i-lamivudine ezifumana iimpawu ezilandelayo kufuneka zithole uncedo lwezonyango olungxamisekileyo: ubuhlungu besisu okanye ubuthakathaka, ubunzima obunzima okanye obubandayo kwiingalo nasemilenzeni, ingxaki yokuphefumula, intlungu yesisu, isicathulo sokuhlanza, ukuhlanza, ukungabi nantliziyo okanye ukungavumelani kwenhliziyo, ukusila, okanye ukuvakalelwa buthathaka okanye ukhathele.
Ukuba une-hepatitis B unokuhlakulela iimpawu zesibindi emva kokuyeka ukuthatha le nyilisi, emva kweenyanga emva kokuyeka. Ugqirha wakho unokufuna ukujonga umsebenzi wakho wesibindi kwiinyanga eziliqela emva kokuyeka ukusebenzisa i-lamivudine. Tyelela ugqirha wakho rhoqo.
Ukongezelela, kubalulekile ukuba ungatshintshi phakathi kwamalungiselelo ahlukahlukeneyo e-lamivudine, kwaye kufuneka unyathelwe rhoqo ngexesha lokuhlaziywa linikezelwa ukuba kulungiselelwa okufanayo. Iipilisi ze-Epivir kunye ne-liquide ziqukethe umthamo ophezulu weziyobisi kune-Epivir-HBV.
Ekugqibeleni, abo basebenzisa iziyobisi bangaphinda bafumane ukunganyangeki kweziyobisi, oku kuthetha ukuba izidakamizwa zingadlulela ngaphaya kwexesha.
Ngubani ongafanelanga ukuthatha uLamivudine
Nabani na ongenayo i-lamivudine akufanele athathe le nkunkuma. Kwakhona kubalulekile ukwazi isimo sakho se-HIV kuba ukuthatha i-lamivudine kunokuba nzima kakhulu ukuphatha i-HIV. Ukuba unayo i-HIV kunye ne-HBV, ungaqalisi unyango lwentsholongwane ngaphandle kokubonisana nodokotela oye wafumana unyango lwezo zibini.
> Imithombo:
US Food and Drug Administration. I-Hepatitis Treaty.
I-UpToDate, iBasow, iDS (Ed), UpToDate, i-Waltham, MA, 2010.